The Untold Story of a Controversial Tanning Drug with Dr. Robert Dorr
This shows that you can, with limited funds, develop a molecule clinically, and I think where this is ultimately going to go is we are going to have a cosmetic type of tanning drug, and it may even be topical in the future.
What if a tanning drug could change the way we think about skin care and cosmetics? In this intriguing episode of 'American Medicine Today', Dr. Robert Dorr, co-author of 'Sex, Diet and Tanning: The Curious Story of the Drug to Induce a Natural Tan', joins the hosts to discuss the fascinating journey behind a controversial tanning drug. This episode offers a deep dive into the drug's origins, initially developed for a rare light sensitivity condition known as erythropoietic protoporphyria. Dr.
Dorr explains how the drug not only alleviates symptoms for those suffering from this condition but also boasts cosmetic benefits that have sparked heated debates. Is it safe for widespread cosmetic use, or should it remain strictly medical? Dr. Dorr shares his insights on this dilemma and the potential impact on the beauty industry. Packed with raw and engaging discussions, this episode sheds light on the complex world of pharmaceuticals, government regulations, and societal perceptions of beauty.
Tune in to discover how a drug intended to treat a medical condition could become the next big thing in cosmetics.